While THA is regarded as one of the most successful surgeries in medicine, recent studies have revealed that ideal acetabular cup implantation is achieved as little as 50% of the time. Malalignment of the acetabular component in THA may result in dislocation, reduced range of motion, or accelerated wear. Recently, robotic-assisted surgery has been introduced to reduce the errors in component placement. The purpose of this study is to longitudinally assess the accuracy of cup placement of a single surgeon at three points in time: directly following a total joint fellowship, after 10 years of experience with manual instrumentation, and directly after adopting robotic technology. Three hundred patients received THA at a single center by a single surgeon representing three series of 100 consecutive patients in each series. The first series A included the surgeon's first 100 THA patients following graduation from joint fellowship (2/2000–5/2002). The second series B included the surgeon's last 100 THA patients before adopting robotic technology (12/2010–1/2012) and the final series C included the surgeon's first 100 THA patients using robotic assistance (4/2012–4/2013). The post-operative abduction and version of the cup was measured using PACS imaging software from the AP and cross-table lateral radiographs. Abduction was measured using a transverse line at the level of the teardrop and the lateral opening angle of the cup relative to this reference line. Anteversion was measured using the ischial method described by Schmalzreid on the crosstable lateral view and accounts for pelvic flexion. The average inclination for the groups A, B, and C was 48.6 ± 7.6°, 37.4 ± 6.2°, and 39.6 ± 47.6°, respectively and for anteversion was 29.3 ± 10.3°, 26.6 ± 8.4°, and 23.6 ± 5.7°, respectively. The cup placement in the original series A was within the Lewinnek safe zone only 31% of the time. This increased to 45% in series B and up to 74% in series C (p < 0.05). With the robotic series C, the three-dimensional pre-operative plan was obtained from the software. The average error (final placement–plan) was −0.7 ± 2.1° for inclination and 1.1 ± 2.0° for version. 93% of the inclination measurements and 94% of the version measurements were within 5° of the plan and 100% of both measurements were within 10° of the plan. Of note, 8% of the robotic cases were actually planned outside of the Lewinnek safe zone to accommodate for patient deformity and optimize correction to achieve the targeted combined anteversion of the acetabular and femoral components. Robotic assistance in THA leads to significantly more precise acetabular cup placement. As measured by the Lewinnek safe zone, 10 years of experience resulted in a 45% increase in precision, while adding robotic assistance resulted in a 139% increase in precision compared to the surgeon's initial performance. With greater knowledge of ideal acetabular cup position, highly accurate techniques may allow surgeons to decrease the risk of dislocation, promote durability and improve the ability to restore appropriate leg length and offset

Dislocation is one of the most common complications in total hip arthroplasty (THA) and is primarily driven by bony or prosthetic impingement. The aim of this study was two-fold. First, to develop a simulation that incorporates the functional position of the femur and pelvis and instantaneously determines range of motion (ROM) limits. Second, to assess the number of patients for whom their functional bony alignment escalates impingement risk. 468 patients underwent a preoperative THA planning protocol that included functional x-rays and a lower limb CT scan. The CT scan was segmented and landmarked, and the x-rays were measured for pelvic tilt, femoral rotation, and preoperative leg length discrepancy (LLD). All patients received 3D templating with the same implant combination (Depuy; Corail/Pinnacle). Implants were positioned according to standardised criteria. Each patient was simulated in a novel ROM simulation that instantaneously calculates bony and prosthetic impingement limits in functional movements. Simulated motions included flexion and standing-external rotation (ER). Each patient's ROM was simulated with their bones oriented in both functional and neutral positions. 13% patients suffered a ROM impingement for functional but not neutral extension-ER. As a result, 48% patients who failed the functional-ER simulation would not be detected without consideration of the functional bony alignment. 16% patients suffered a ROM impingement for functional but not neutral flexion. As a result, 65% patients who failed the flexion simulation would not be detected without consideration of the functional bony alignment. We have developed a ROM simulation for use with preoperative planning for THA surgery that can solve bony and prosthetic impingement limits instantaneously. The advantage of our ROM simulation over previous simulations is instantaneous impingement detection, not requiring implant geometries to be analysed prior to use, and addressing the functional position of both the femur and pelvis

Smartphone-based apps that measure step-count and patient reported outcomes (PROMs) are being increasingly used to quantify recovery in total hip arthroplasty (THA). However, optimum patient-specific activity level before and during THA early-recovery is not well characterised. This study investigated 1) correlations between step-count and PROMs and 2) how patient demographics impact step-count preoperatively and during early postoperative recovery. Smartphone step-count and PROM data from 554 THA patients was retrospectively reviewed. Mean age was 64±10yr, BMI was 29±13kg/m2, 56% were female. Mean daily step count was calculated over three time-windows: 60 days prior to surgery (preop), 5–6 weeks postop (6wk), and 11–12 weeks postop (12wk). Linear correlations between step-count and HOOS12 Function and UCLA activity scores were performed. Patients were separated into three step-count levels: low (<2500steps/day), medium (2500-5500steps/day), and high (>5500steps/day). Age >65years, BMI >30, and sex were used for demographic comparisons. Student's t-tests determined significant differences in mean step-counts between demographic groups and in mean PROMs between step-count groups. UCLA correlated with step-count at all time-windows (p<0.01). HOOS12 Function correlated with step-count preoperatively and at 6wk (p<0.01). High vs low step count individuals had improved UCLA scores preoperatively (∆1.8,p<0.001), at 6wk (∆1.1,p<0.05), and 12wk (∆1.6,p<0.01), and improved HOOS12 Function scores preoperatively (∆8.4,p<0.05) and at 6wk (∆8.8,p<0.001). Younger patients had greater step-count preoperatively (4.1±3.0k vs 3.0±2.5k, p<0.01) and at 12wk (5.1±3.3k vs 3.6±2.9k, p<0.01). Males had greater step-count preoperatively (4.1±3.0k vs. 3.0±2.7k, p<0.001), at 6wk (4.5±3.2k vs 2.6±2.5k, p<0.001), and at 12wk (5.2±3.6k vs. 3.4±2.5k, p<0.001). Low BMI patients had greater step-count at 6wk (4.3±3.3k vs. 2.6±2.7k, p<0.01) and 12wk (5.0±3.6k vs. 3.6±2.6k, p<0.05). Daily step-count is significantly impacted by patient demographics and correlates with PROMs, where patients with high step count exhibit improved PROMs. Generic recovery profiles may therefore not be appropriate for benchmarking across diverse populations

We report the outcome of 320 primary Total Hip Arthroplasties (THA) with minimum 10-year follow-up (range 10–17 years, mean 12.6 years), performed by a single surgeon in Tauranga New Zealand, with the Exeter Contemporary Flanged all-polyethylene cup and Exeter femoral stem via a posterior approach. The aim of the study is to compare the results with the published results from the design centre and create a baseline cohort for further outcomes research in this centre. All patients were prospectively followed at 6 weeks, 1 year, 5 years, 10 years, (and 15 years when available). Of 333 cases that matched the inclusion criteria, 13 procedures in 12 patents were excluded because of concomitant bone grafting and/or supplementary cage fixation, leaving 320 primary THA procedures in 280 patients, including 26 bilateral procedures in 13 patients. Mean follow-up of the surviving cases was 12.6 (range 5.0-17.1) years. There were 12 revisions – 2 for fracture, 5 for instability, 1 for impingement pain and 4 for infection. There were no revisions for aseptic cup loosening. Kaplan-Meier survivorship with revision for aseptic loosening as the endpoint was 100% at 15.0 years (with minimum 40 cases remaining at risk). All-cause acetabular revision in 12 cases result in a Kaplan-Meier survival of 95.9% (95% CI: 93.5 to 98.3%). Cemented THA with the Exeter Contemporary Flanged cup and the Exeter stem is a durable combination with results that can be replicated outside of the design centre. The Exeter Contemporary Flanged cup has excellent survivorship at 15 years when used with the Exeter stem. Cemented THA with well-proven components should be considered the benchmark against which newer designs and materials should be compared

Acetabular implant position is important for the stability, function, and long-term wear properties of a total hip arthroplasty (THA). Prior studies of acetabular implant positioning have demonstrated a high percentage of outliers, even in experienced hip surgeons, when conventional instruments are used. Computer navigation is an attractive tool for use in THA, as it has been shown to improve the precision of acetabular component placement and reduce the incidence of outliers. However, computer navigation with imageless, large-console systems is costly and often interrupts the surgeon's workflow, and thus, has not been widely adopted. Another method to improve acetabular component positioning during THA is the use of fluoroscopy with the direct anterior approach. Studies have demonstrated that the supine position of the patient during surgery facilitates the use of fluoroscopic guidance, thus improving acetabular component position. A handheld, accelerometer-based navigation unit for use in total hip replacement has recently become available to assist the surgeon in positioning the acetabular component during anterior approach THA, potentially reducing the need for intra-operative fluoroscopic studies. We sought to compare the radiographic results of direct anterior THA performed with conventional instrumentation vs. handheld navigation to determine the accuracy of the navigation unit, and to see whether or not there was a reduction in the fluoroscopic time used during surgery. Furthermore, we timed the use of the navigation unit to see whether or not it required a substantial addition to surgical time. Our results demonstrate that a handheld navigation unit used during anterior approach THA had no difference with regard to acetabular cup positioning when compared to fluoroscopically assisted THA, but led to a reduction in the use of intra-operative fluoroscopy time

As the American population ages and a trend toward performing total hip arthroplasty (THA) in younger patients continues, the number of Americans undergoing THA is projected to increase over time. The advent of the bundled payment system combined with the current medical utilization climate has placed considerable pressure on surgeons to produce excellent results with early functional recovery and short hospital stays. The US obesity epidemic has transcended into the arthroplasty patient population and surgeons must assess whether obesity is a risk factor for poor outcomes in THA and determine how it should be managed. We performed a recent literature review to determine how obesity impacts outcomes in total hip arthroplasty and what must be done to improve outcomes in the obese arthroplasty patient. Our goal is to answer 3 questions: does obesity increase the complication rate in THA, if obesity matters how obese is too obese, and what must be done to improve outcomes in the obese patient?. Ultimately, obesity has been shown to correlate with increased post-operative complications in THA. The arthroplasty surgeon must optimise the obese patient prior to surgery by identifying associated comorbidities and consider malnutrition screening with counseling. Notice should be taken of the degree of obesity as patients with BMI > 40 have demonstrated much higher complication rates. Strong consideration should be given to avoiding direct anterior approach in the obese patient. Healthy weight loss must be encouraged with appropriate patient counseling and treatment in order to achieve success with THA in obese patients.  

Femoral trans-trochanteric rotational osteotomy(TRO) is widely used for the younger patients who have idiopathic osteonecrosis of femoral head. However, it usually converts to THA, and in hip arthroplasty, the procedure is commonly technically demanding and surgeon needs higher level of surgical technique. This study was designed to investigate comparison between simple THA and THA following TRO, and indicates specific surgical techniques of THA following TRO. Materials and Methods. Between 2002 and 2012, the senior authors performed 20 cementless THA in 16 patients who had followed after TRO. The operation time, blood loss, post-operative X-ray findings, and overall clinical results (JOA score) were investigated. These data were compared with simple THA following 10 years. Results. A mean duration between TRO and THA was 58 month, a mean age at the time of THA was 52.1 years old. Pre-operative classification was all Type C and stage 2 or higher stage. Osteonecrosis of femoral head before THA was mean 56.2%. Operation time was 160 minutes, and mean blood loss was 764 g. In post-operative X-ray findings, a cup was at original anatomy in place in all cases. There is a tendency of slight varus femoral stem position after THA following TRO. The JOA score was improved from 42.1 to 74.2. Discussion. Technically, there are a couple of issues in THA following TRO. Specific surgical techniques are needed. Surgical results depend on hip range of motion before THA. There is a difficulty of improvements in ROM after THA following TRO

Introduction. Accurate acetabular cup orientation could lead to successful surgical results in total hip arthroplasty (THA). We introduce a novel CT-based three-dimensional (3D) planning system, HipCOMPASS (Fig.1) and TARGET (Fig.2), which enable to design suitable alignment not only cup also surgical devices calculatingly, according to each pelvic inclination. Patients and Methods. We performed THA in 45 hips in 43 patients (female 37 and 6 men) between April 2014 and October 2015. Average age were 68 years old. THA operation was based on each parameter of the cup and device, providing a preoperative planning by ZedView system. HipCOMPASS and TARGET is linked with ZedView software, which is simultaneously calibrated adjustable parameters on this devices. Cup alignment was assessed by ZedView as well. Results. The differences of component alignment from the preoperative planning were shown in Tables. Conclusion. HipCOMPASS and TARGET might be more accurate than conventional method and more accessible system than navigation system in THA

Arthritis of the hip is a relatively common problem in patients with neuromuscular disorders due to muscle imbalance around the hip from weakness, paralysis, contractures and spasticity. Neuromuscular disorders such as cerebral palsy, Parkinson's disease, poliomyelitis, previous cerebrovascular accident (CVA) and Charcot arthropathy have been considered by many to be contraindications to total hip arthroplasty (THA). The presence of certain anatomic abnormalities (excessive femoral anteversion, acetabular dysplasia, leg length discrepancy (LLD) and coax valga) and significant soft tissue contractures, muscle imbalance, and muscular weakness make THA a challenging surgical procedure in this patient population, and can predispose to dislocation and poor functional outcome following surgery. THA can, however, result in substantial pain relief and functional improvement, and can be safely performed, provided certain technical considerations are addressed. The patient's motor strength and functional status (ambulatory vs. “sitter”) should be carefully assessed preoperatively, since both of these factors may affect the choice of surgical approach and component position. Significant soft tissue contractures should be released at the time of surgery. Although these can be frequently performed “open”, percutaneous adductor tenotomy is occasionally necessary for patients with significant adduction contractures. Patients requiring significant soft tissue releases may benefit from 6 weeks of bracing to allow soft tissues to heal in appropriately and minimise risk of dislocation during this period of time. Use of modular femoral components that allow for correction of excessive femoral anteversion, should be considered in patients with coexistent dysplasia and neuromuscular disease (i.e., CP or polio). Large femoral head components should also be considered in patients with increased risk factors for dislocation. Despite their obvious theoretical advantages, the use of large head metal on metal THAs should be used with extreme caution in view of growing concerns about these devices. Although constrained acetabular liners are associated with an increased risk of mechanical failure, their use should be strongly considered in patients with significant motor weakness or major soft tissue deficiencies. Meticulous soft tissue closure of the capsule of the hip is recommended, especially when performing THA through a posterior approach. Patients with neuromuscular disorders associated with spasticity and involuntary movements need to be optimally treated medically prior to and indefinitely after THA. There are limited reports of outcomes following THA in patients with neuromuscular disorders, however, some generalizations based on underlying diagnosis can be made. Patients with cerebral palsy and polio frequently have acetabular dysplasia, excessive femoral anteversion and LLD, and although durability does not seem to be a major concern, dislocation and instability is relatively common and needs to be addressed. Durability and instability do not appear to be major concerns in patients with Parkinson's disease, however, these patients have frequent medical complications perioperatively and have deterioration in function over time due to the progressive nature of their underlying disorder. Patients with previous CVA also appear to have acceptable durability and dislocation risk, but are at high risk of developing heterotopic ossification postoperatively. Patients with Charcot arthropathy or myelodysplasia are at high risk of instability and appear to have limited functional improvement following THA. As a result, the consensus of opinion is that THA is contraindicated in these patients

Introduction. Accurate acetabular cup orientation could lead to successful surgical results in total hip arthroplasty (THA). We introduce a novel CT-based three-dimensional (3D) planning system, HipCOMPASS (Fg.1) and TARGET (Fig.2), which enable to design suitable alignment not only cup also surgical devices calculatingly, according to each pelvic inclination. Patients and methods. We performed THA in 13 patients (10 female and 3 men) between September 2014 and April 2014. Average age were 67 years old. THA operation was based on each parameter of the cup and device, providing a preoperative planning by ZedView system. HipCOMPASS and TARGET is linked with ZedView software, which is simultaneously calibrated adjustable parameters on this devices. Cup alignment was assessed by ZedView as well. Result. The differences of component alignment from the preoperative planning were shown in table. Conclusion. HipCOMPASS and TARGET might be more accurate than conventional method and more accessible system than navigation system in THA

An outpatient total hip arthroplasty (THA) will be defined as a THA performed at an ambulatory care facility where the patient is discharged the same day as the procedure. Such procedures are being done in the United States and the hypothesis is that a “same day” THA will lead to reduced costs and improved outcomes. However, there are no appropriately powered randomised controlled trials evaluating outcomes in this group of patients to support this hypothesis. It appears that a “same day” THA is here to stay. Therefore, the selection criteria for patients that undergo the procedure needs to be carefully defined. The safety of this regimen needs to be confirmed. In an evaluation of the NSQIP database, Otero et al. compared outcomes in patients discharged on POD 0 and POD 1 and noted that THA patients in the POD 0 group had increased rates of complications. Risk factors for complications included age >70, smoking, COPD, CAD and hematocrit less than 36. In addition, the patients discharged on POD 0 had higher rates of diabetes, steroid use and lower hematocrit. Clearly, the selection criteria for this procedure needs to be defined. In two separate studies, Goyal et al. and Dorr et al. noted that approximately 25% of patients were unable to leave the hospital on POD 0 usually because of nausea and/or hypertension. Issues to consider before developing a same day discharge program include: 1) Is the patient healthy enough to go home the same day as the surgery?; 2) Does the patient live close enough to the hospital to be discharged the same day?; 3) Can the family provide the appropriate care for the patient at home?; 4) Is it really better for the patient or just better for the surgeon?. If a surgeon embarks on a same day discharge program, rigorous selection criteria must be instituted and followed. In addition, the patient must have free choice with respect to a same day discharge versus a 24-hour stay

The goal is to avoid letting femoral deformity force suboptimal implant position/fixation. Suboptimal implant position has an adverse effect on hip biomechanics and often on hip function and durability. Classification - Practical approach to femoral deformities: categorise into 3 main groups: 1.) Very proximal, 2.) Subtrochanteric, 3.) Distal. Management of distal deformities: Most can be ignored if there is sufficient room to place conventional femoral implant. Management of proximal deformities: Option 1: Use implants that allow satisfactory positioning despite deformity…or… Option 2: Remove the deformity. Management of subtrochanteric level deformities: These are the most difficult. Problems: 1.) Too proximal to ignore, 2.) Too distal to bypass. Main treatment options: 1.) Resurfacing THA, 2.) Short stem THA, 3.) Corrective osteotomy with THA. Corrective osteotomy with THA: 1.) Perform osteotomy at level of deformity, 2.) In most cases a corrective osteotomy that creates a transverse osteotomy junction is simplest, 3.) Use an implant that provides reliable fixation in the femur (usually uncemented), 4.) Use implant that provides fixation of the proximal and distal fragments. Majority of proximal femoral deformities managed with one-stage procedure: 1.) Excise deformity and replace with metal, 2.) Implants that allow ignoring deformity, 3.) Corrective osteotomy

Osteolysis is one of a major cause of failure that affect long term survival rate in THA. Hard-on-hard bearing surface were developed to reduce wear and osteolysis, such as ceramic-on-ceramic which is the lowest wear rate was introduced but it still has squeaking and ceramic fracture. Metal-on-metal bearing surface significantly reduce wear rate but it still release metal ion which affect local tissue reaction. Then ceramic-on-metal is another choice of bearing with combine the advantage of reduce wear rate, metal ion release, no stripe wear, no squeaking and no ceramic fracture. However after clinical use ALTRs may occur and disturb the longevity of THA. During January 2009 to December 2009 we performed 98 THR with the same femoral stem and acetabular cup with difference bearing which were 87 cases of metal on cross-linked PE, 8 cases of ceramic on metal and 5 cases of metal on metal. Routinely postoperative care were done with clinical evaluation, plain x-rays and Harris hip score. After 5 years follow up there are clinical problems in ceramic on metal THA with decrease clinical score and progressive osteolysis in radiographic finding in 2 cases then we investigated to find the cause of this problem and revise the components. We preformed magnetic resonance imaging and collect blood sample for ESR, CRP and Cobalt and Chromium level. We revised 2 cases of ceramic on metal THA, during surgery we collected tissue for bacterial and AFB and histopathology. All retrieval components were studied for wear pattern. First patient have thigh pain and progressive osteolysis after year 4. th. of follow up. She had normal ESR and CRP with high level of cobalt and chromium level. We revised both components and tissue histopathology showed metallosis with chronic inflammation. Another patient had failure due to ALTRs with mixed solid-cystic mass at trochanteric bursa but component is stable then only bearing surface were change. Wear pattern at femoral head was in weight bearing area with corresponding to apical center wear of metal liner. Our study showed that only in group of ceramic-on-metal THA that have 5 years follow up have early reoperation due to osteolysis and tissue reaction. We routinely stop to use this bearing since 2010. But we have small number of cases in our study to conclude that is bearing are not suitable for clinical usage

(Introduction). Metal on Metal (MoM) THA bearing as the second generation Total Hip Arthroplasty, widely came into use in Japan since 2000s. And it was expected to be able to ensure long-term use, the range of motion in the joints after surgeries, and the resistance to the dislocation, because MoM THAhad been considered to be able to use the large diameter head for its lower wear. However, there are some reports that the metal wear debris from MoM bearing surface generates the elevated serum ion level in the blood and the incidence of pseudotumor may occur subsequent to the metal wear debris. We performed MoM THA for 291 joints in 234 patients in our hospital since May 2005. But now, we refrain to use this. In this time, we will describe two cases of pseudotumor after implantation of MoM THA. (Case1) Age 64 years, female. This case showed the hip osteoarthritis on the right side, and we performed MoM THA in 2005. After that, she had slipped just prior to the three-year postoperative check-up, andstarted swelling up, hip joint pain, and the rise in CRP. Then, we performed to remove pesudotumor in 2008 and her CRP turned into negative. However, she was repeating hip dislocation several times and an MRI showed recur of pseudotumor. Finally, we changed her metal liner into a polyethylene liner in 2012. (Case2) Age 57 years, female. This case showed the hip osteoarthritis on the bilateral side, and we performed MoM THA in 2005. We had regularly measured her serum ion levels since 2009, and her cobalt level was indicating high concentration. In addition, there was shown 46ng/ml blood concentration of cobalt in her postoperative check-up in 2013. In 2014, she came to our hospital with chief complaint of the pain in the right groin, and we confirmed pseudotumor with MRI. (Conclusion). Nowadays, there have been various reports regarding the formation of mass lesion around the joint implants with MoM bearing, and the incidence rates, the methods of the diagnosis, and the treatment policies are introduced. However, they are realistically still not standardized. For this reason, we should fully understand the properties of MoM THA to perform the surgeries. And there is a need to be performed CT scans, MRI and ultrasound examination for the patients who claim a pain or the sense of discomfort in the area after surgery

Intra-operative fractures of the femur are on the rise mainly due to the increased use of cementless implants and the desire to get a tight press fit. The prevalence has been reported to be between 1–5% in cementless THAs. The key to preventing these fractures is to identify patients at high risk and careful surgical technique. Surgical risk factors include the use of cementless devices, revision hip surgery, the use of flat tapered wedges and MIS surgery. Patient factors that increased risk include increasing age, female gender, osteopenia and rheumatoid arthritis. These risk factors tend to be additive and certainly when more than one is present extra caution needs to be taken. Surgical technique is critical to avoid these intra-operative fractures. Fractures can occur during exposure and dislocation, during implant removal (in revision THA), during canal preparation and most commonly during stem insertion. In both primary, and especially in revision, THA be wary of the stiff hip in association with osteopenia or osteolysis. These patients require a very gentle dislocation. If this cannot be achieved, then alteration of the standard approach and dislocation may be needed. Examples of these include protrusion with an osteopenic femur and revision THA with a very stiff hip with lysis in the femur. Lastly, in cases with retained hardware, dislocate prior to removing plates and screws. After dislocation, the next challenge is gentle preparation of the femoral canal. A reasonable exposure is required to access the femoral canal safely. MIS procedures do not offer good access to femoral canal and this probably results in increased risk of fracture during broaching or implant insertion. When broaching, stop when broach will not advance further. When inserting a tapered wedge stem, be worried if stem goes further in than broach. In revision surgery, when taking the stem out from above, make sure the area of the greater trochanter does not overhang the canal. A high speed burr can clear the shoulder for easier access for removal. In revision THA with an ETO, place a cerclage wire prior to reaming and retighten prior to stem insertion. Even with careful surgical technique intra-operative femoral fractures will still occur. When inserting the stem, a sudden change in resistance is highly suggestive of fracture. Wide exposure of the entire proximal femur is necessary to confirm the diagnosis. The distal extent of the fracture must be seen. Only on occasion is an intra-operative radiograph needed. Management is directed to ensuring component stability and good fracture fixation. In primary total hip arthroplasty, calcar fractures are by far the most common. If using proximal fixation and you are certain the stem is stable, then all that is needed is cerclage wiring. As already mentioned, you must follow the fracture line distally so you are aware of how far down it goes. Often what appears to be a calcar split actually propagates distal to the lesser trochanter. In these cases, one would probably go for distal fixation plus wiring. In conclusion, intra-operative femoral fractures are on the rise. Prevention is the key

Arthritis of the hip is a relatively common problem in patients with neuromuscular disorders due to muscle imbalance around the hip from weakness, paralysis, contractures and spasticity. Neuromuscular disorders such as cerebral palsy, Parkinson's disease, poliomyelitis, previous cerebrovascular accident (CVA) and Charcot arthropathy have been considered by many to be relative contraindications to total hip arthroplasty (THA). The presence of certain anatomic abnormalities (excessive femoral anteversion, acetabular dysplasia, leg length discrepancy (LLD) and coax valga) and significant soft tissue contractures, muscle imbalance, and muscular weakness make THA a challenging surgical procedure in this patient population, and can predispose to dislocation and poor functional outcome following surgery. THA can, however, result in substantial pain relief and functional improvement in patients with significant hip arthritis and neuromuscular disorders, and can be safely performed, provided certain technical considerations are addressed. The patient's motor strength and functional status (ambulatory vs. “sitter”) should be carefully assessed pre-operatively, since both of these factors may affect the choice of surgical approach and component position. Significant soft tissue contractures should be released at the time of surgery. Although these can be frequently performed “open”, percutaneous adductor tenotomy is occasionally necessary for patients with significant adduction contractures. Patients requiring significant soft tissue releases may benefit from 6 weeks of bracing to allow soft tissues to heal appropriately and minimise risk of dislocation during this period of time. Use of modular femoral components that allow for correction of excessive femoral anteversion, should be considered in patients with coexistent dysplasia and neuromuscular disease (i.e. CP or polio). Large femoral head components should also be considered in patients with increased risk factors for dislocation. Despite their obvious theoretical advantages, the use of large head metal on metal THAs should be used with extreme caution in view of growing concerns about these devices. Although constrained acetabular liners are associated with an increased risk of mechanical failure, their use should be strongly considered in patients with significant motor weakness or major soft tissue deficiencies. Meticulous soft tissue closure of the capsule of the hip is recommended, especially when performing THA through a posterior approach. Patients with neuromuscular disorders associated with spasticity and involuntary movements need to be optimally treated medically prior to and indefinitely after THA. There are limited reports of outcomes following THA in patients with neuromuscular disorders, however some generalisations based on underlying diagnosis can be made. Patients with cerebral palsy and polio frequently have acetabular dysplasia, excessive femoral anteversion and LLD, and although durability does not seem to be a major concern, dislocation and instability is relatively common and needs to be addressed. Durability and instability do not appear to be major concerns in patients with Parkinson's disease, however, these patients have frequent medical complications perioperatively and have deterioration in function over time due to the progressive nature of their underlying disorder. Patients with previous CVA also appear to have acceptable durability and dislocation risk, but are at high risk of developing heterotopic ossification postoperatively. Patients with Charcot arthropathy or myelodysplasia are at high risk of instability and appear to have limited functional improvement following THA. As a result, the consensus of opinion is that THA is contraindicated in patients with Charcot arthropathy and myelodysplasia

Introduction: The goal is to avoid letting femoral deformity force suboptimal implant position/fixation. Suboptimal implant position has an adverse effect on hip biomechanics and often on hip function and durability. Classification: Practical approach to femoral deformities: categorise into 3 main groups: Very proximal, Subtrochanteric, Distal. Management: Management of distal deformities: Most can be ignored if there is sufficient room to place conventional femoral implant. Management of proximal deformities: Option 1: Use implants that allow satisfactory positioning despite deformity…or… Option 2: Remove the deformity. Management of subtrochanteric level deformities: These are the most difficult. Problems: Too proximal to ignore, Too distal to bypass. Main treatment options: Resurfacing THA, Short stem THA, Corrective osteotomy with THA. Corrective osteotomy with THA: Perform osteotomy at level of deformity, In most cases a corrective osteotomy that creates a transverse osteotomy junction is simplest, Use an implant that provides reliable fixation in the femur (usually uncemented), Use implant that provides fixation of the proximal and distal fragments. Conclusions: Majority of proximal femoral deformities managed with one-stage procedure: Excise deformity and replace with metal, Implants that allow ignoring deformity, Corrective osteotomy

Aim. Prosthetic joint infection (PJI) is a major complication in THA. Nasal carriage with S. Aureus is a well-defined risk factor for infection in hospitalized patients. Risk for infection is reduced up to 50% by eradication therapy. Since PJI rates are very low and only 25% of the population are carriers, significant differences are hard to show and reports on PJI have been inconclusive. We analysed the effect of S. Aureus eradication therapy in THA. Methods. From 2011, patients receiving THA are screened for S. Aureus carriage and carriers are treated. This group was retrospectively compared with a historical THA group in which no screening and eradication therapy was done. We assumed similar carrier rates in both groups and calculated the risk reduction of eradication therapy for PJI in comparison to the historical carriers without treatment. Fisher's Exact test was used to compare outcome. Results. 2072 patients were screened and 478 patients were positive (23%). The historical control group consisted of 1248 patients, with 288 calculated carriers (23%). 15 PJI (0.72%) occurred vs 14 (1.12%) in the historical group (p=0.16). A 52% reduction in S. Aureus infections was found (0.33% vs 0.64% p=0.15). Infection rates for PJI caused by S. aureus was similar in non-carriers and carriers after eradication therapy (0.3 vs 0.4% p=0.506). The calculated infection rates in carriers in the historical group was reduced from 2.6% to 0.8% (RR 3,25, p=0.07) by eradication therapy and from 1.7% to 0,4% (RR 4,25, p=0.07) for S. Aureus PJI. Conclusions. A clear trend in reduction of PJI was demonstrated as a result of S. aureus screening and eradication therapy, reducing the rate of PJI for carriers to the same level as non-carriers

Background. Fifteen to twenty percent of patients presenting for total hip arthroplasty (THA) have bilateral disease. While simultaneous bilateral THA is of interest to patients and surgeons, debate persists regarding its merits. The majority of previous reports on simultaneous bilateral THA involve patients in the lateral decubitus position, which require repositioning, prepping and draping, and exposure of a fresh wound to pressure and manipulation for the contralateral THA. The purpose of this study was to compare complications, component position, and financial parameters for simultaneous versus staged bilateral THAs using the direct anterior approach (DAA). Methods. Medical records were reviewed for patient demographics, medical history, operative time, estimated blood loss (EBL), change in hemoglobin, transfusion, tranexamic acid (TXA) use, length of stay (LOS), discharge disposition, leg length discrepancy, acetabular cup position, and perioperative complications. Cost and reimbursement data were analyzed. Results. Forty-four patients were included in the sequential group and fifteen patients in the simultaneous group (Figure 1). Operative time was significantly longer for simultaneous DAA THA, with procedures lasting 260 +/− 48 minutes compared to 132 +/− 30 minutes for a single arthroplasty in the sequential group (p<0.001). Patients undergoing simultaneous bilateral DAA THA also had a significantly higher EBL (p<0.001), hemoglobin drop (p<0.001), and blood transfusion rate (p<0.01) compared to parameters for a single arthroplasty in the sequential group. This was despite TXA being used in a significantly higher proportion of simultaneous procedures compared to sequential procedures (p<0.01). The LOS was significantly longer in patients undergoing simultaneous bilateral DAA THA (2.9 +/− 1.0 days) compared to sequential (2.2 +/− 0.6 days) (p<0.001). No deep venous thrombosis (DVT) or pulmonary embolism (PE) was detected in either group during the observation period. No significant difference was detected regarding perioperative complications or whether patients were able to be discharged home instead of to a post-inpatient facility (Figure 2). There was no significant difference in component position, complications, or readmissions between groups. Total cost per hip was significantly less for the simultaneous ($15,565 +/− 1,470) compared to the sequential group ($19,602 +/− 3,094) (p<0.001). There was no significant difference in total payments between the simultaneous group ($25,717 +/− 4,404) and the sequential group ($24,926 +/− 8,203) (p=0.93). Thus, with lower cost and similar reimbursement, profit per hip was significantly higher for the simultaneous ($9,606 +/− 5,060) compared to the sequential group ($5,324 +/− 7,997) (p<0.05). (Figure 3). Conclusions. Significant data regarding simultaneous bilateral THA has been published but results are conflicting and different surgical approaches were used. To our knowledge only four previous reports have been published examining simultaneous bilateral THA performed via the DAA. While simultaneous DAA THA presents challenges, our results suggest that simultaneous DAA THA may add value to the healthcare system without resulting in increased complications compared to sequential hip arthroplasty

Arthritis of the hip is a relatively common problem in patients with neuromuscular disorders due to muscle imbalance around the hip from weakness, paralysis, contractures and spasticity. Neuromuscular disorders such as cerebral palsy, Parkinson's disease, poliomyelitis, previous cerebrovascular accident (CVA) and Charcot arthropathy have been considered by many to be relative contraindications to total hip arthroplasty (THA). The presence of certain anatomic abnormalities (excessive femoral anteversion, acetabular dysplasia, leg length discrepancy (LLD) and coax valga) and significant soft tissue contractures, muscle imbalance, and muscular weakness make THA a challenging surgical procedure in this patient population, and can predispose to dislocation and poor functional outcome following surgery. THA can, however, result in substantial pain relief and functional improvement in patients with significant hip arthritis and neuromuscular disorders, and can be safely performed, provided certain technical considerations are addressed. The patient's motor strength and functional status (ambulatory vs. “sitter”) should be carefully assessed pre-operatively, since both of these factors may affect the choice of surgical approach and component position. Significant soft tissue contractures should be released at the time of surgery. Although these can be frequently performed “open,” percutaneous adductor tenotomy is occasionally necessary for patients with significant adduction contractures. Patients requiring significant soft tissue releases may benefit from 6 weeks of bracing to allow soft tissues to heal in appropriately and minimize risk of dislocation during this period of time. Use of modular femoral components that allow for correction of excessive femoral anteversion, should be considered in patients with coexistent dysplasia and neuromuscular disease (i.e. CP or polio). Large femoral head components should also be considered in patients with increased risk factors for dislocation. Despite their obvious theoretical advantages, the use of large head metal on metal THAs should be used with extreme caution in view of growing concerns about these devices. Although constrained acetabular liners are associated with an increased risk of mechanical failure, their use should be strongly considered in patients with significant motor weakness or major soft tissue deficiencies. Meticulous soft tissue closure of the capsule of the hip is recommended, especially when performing THA through a posterior approach. Patients with neuromuscular disorders associated with spasticity and involuntary movements need to be optimally treated medically prior to and indefinitely after THA. There are limited reports of outcomes following THA in patients with neuromuscular disorders, however some generalisations based on underlying diagnosis can be made. Patients with cerebral palsy and polio frequently have acetabular dysplasia, excessive femoral anteversion and LLD, and although durability does not seem to be a major concern, dislocation and instability is relatively common and needs to be addressed. Durability and instability do not appear to be major concerns in patients with Parkinsons disease, however, these patients have frequent medical complications perioperatively and have deterioration in function over time due to the progressive nature of their underlying disorder. Patients with previous CVA also appear to have acceptable durability and dislocation risk, but are at high risk of developing heterotopic ossification post-operatively. Patients with Charcot arthropathy or myelodysplasia are at high risk of instability and appear to have limited functional improvement following THA. As a result, the consensus of opinion is that THA is contraindicated in patients with Charcot arthropathy and myelodysplasia